Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses

International Journal of Molecular Sciences
María-Teresa García-ConesaAntonio González-Sarrías

Abstract

Understanding interindividual variability in response to dietary polyphenols remains essential to elucidate their effects on cardiometabolic disease development. A meta-analysis of 128 randomized clinical trials was conducted to investigate the effects of berries and red grapes/wine as sources of anthocyanins and of nuts and pomegranate as sources of ellagitannins on a range of cardiometabolic risk biomarkers. The potential influence of various demographic and lifestyle factors on the variability in the response to these products were explored. Both anthocyanin- and ellagitannin-containing products reduced total-cholesterol with nuts and berries yielding more significant effects than pomegranate and grapes. Blood pressure was significantly reduced by the two main sources of anthocyanins, berries and red grapes/wine, whereas waist circumference, LDL-cholesterol, triglycerides, and glucose were most significantly lowered by the ellagitannin-products, particularly nuts. Additionally, we found an indication of a small increase in HDL-cholesterol most significant with nuts and, in flow-mediated dilation by nuts and berries. Most of these effects were detected in obese/overweight people but we found limited or non-evidence in normowe...Continue Reading

Associated Clinical Trials

References

Mar 15, 1996·Clinica Chimica Acta; International Journal of Clinical Chemistry·D M GoldbergC R Pace-Asciak
Dec 31, 1997·Controlled Clinical Trials·M D FlatherS Yusuf
Aug 13, 1998·The American Journal of Clinical Nutrition·S V NigdikarA N Howard
Apr 11, 2001·Free Radical Biology & Medicine·R Abu-Amsha CaccettaK D Croft
Aug 22, 2001·Journal of Agricultural and Food Chemistry·M P KähkönenM Heinonen
Nov 6, 2001·The Journal of Nutrition·K J AndersonF M Steinberg
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
May 21, 2004·Internal Medicine Journal·A P WhelanM J A Williams
Sep 20, 2005·The American Journal of Cardiology·Michael D SumnerDean Ornish
Jan 31, 2006·The American Journal of Cardiology·Sidney C Smith
Jan 31, 2007·Journal of Agricultural and Food Chemistry·Jani M KoponenA Riitta Törrönen
Mar 27, 2007·The British Journal of Nutrition·Janine Mukuddem-PetersenZelda White
Aug 8, 2007·Journal of the Cardiometabolic Syndrome·Jan BasileCarlos M Ferrario
Oct 24, 2007·The Journal of Nutrition·Randi L EdwardsThunder Jalili
Dec 7, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Jonas SpaakJohn S Floras
Feb 9, 2008·The American Journal of Clinical Nutrition·Iris ErlundAntti Jula
May 6, 2008·Nutrition Journal·Kim J SpaccarotellaTerryl J Hartman
May 20, 2008·Nutrition·Jara Pérez JiménezFulgencio Saura-Calixto
Nov 18, 2008·Metabolism: Clinical and Experimental·David J A JenkinsWilliam Singer
Dec 19, 2008·Critical Reviews in Food Science and Nutrition·Emre BakkalbaşiNevzat Artik
Jul 18, 2009·Metabolism: Clinical and Experimental·Brahmesh SivaprakasapillaiTissa Kappagoda
Oct 13, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·R EstruchA Urbano-Marquez

❮ Previous
Next ❯

Citations

Sep 11, 2018·Current Opinion in Clinical Nutrition and Metabolic Care·Emilio RosAleix Sala-Vila
Aug 1, 2019·Nutrition Reviews·Daniela MartiniMarisa Porrini
Sep 25, 2019·The Proceedings of the Nutrition Society·Eileen R Gibney
Apr 14, 2020·International Journal of Food Sciences and Nutrition·Margherita Dall'AstaFurio Brighenti
Apr 23, 2020·International Journal of Food Sciences and Nutrition·Alice RosiFrancesca Scazzina
Aug 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hélder OliveiraIva Fernandes
Feb 6, 2020·The Proceedings of the Nutrition Society·Christine MorandFrancisco Tomas-Barberan
Jun 21, 2020·Genes & Nutrition·N Vázquez-ManjarrezC Manach
Aug 12, 2018·Diseases·Eleni PavlidouConstantinos Giaginis
Jun 28, 2019·Plant Foods for Human Nutrition·Fatima S PoswalVivien Rolfe
Feb 8, 2020·Nutrients·María-Teresa García-Conesa, Mar Larrosa
Feb 28, 2020·European Journal of Nutrition·Maria M UlaszewskaFulvio Mattivi
Aug 30, 2020·International Journal of Molecular Sciences·Daniel A Jacobo-Velázquez, Luis Cisneros-Zevallos
Oct 23, 2019·European Journal of Nutrition·Christine Morand, Francisco A Tomás-Barberán
Oct 11, 2020·Nature Reviews. Cardiology·Pedro L ValenzuelaAlejandro Lucia
Feb 4, 2021·Journal of Agricultural and Food Chemistry·Paula S FerreiraThais B Cesar
Dec 9, 2020·Antioxidants·Antonio J AmorIolanda Lázaro
Feb 7, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Vicente AgullóCristina García-Viguera
Nov 5, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Simona MinzerRosa Casas
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Levi EvansBradley S Ferguson

❮ Previous
Next ❯

Software Mentioned

GRADE
Comprehensive Meta - Analysis Software

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Frontiers in Bioscience (Elite Edition)
Christina-Maria Kastorini, Demosthenes B Panagiotakos
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
P Casas-AgustenchJordi Salas-Salvadó
Oxidative Medicine and Cellular Longevity
Gemma Chiva-Blanch, Lina Badimon
© 2022 Meta ULC. All rights reserved